STU 3 Candidate

This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3

V2-0227.vs.xml

Raw XML (canonical form)

FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v2-0227"/>
  <meta>
    <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/>
  </meta>
  <text>
    <status value="additional"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p>Manufacturers of Vaccines (code=MVX)</p>

      <table class="grid">
        <tr>
          <td>
            <b>Code</b>
          </td>
          <td>
            <b>Description</b>
          </td>
          <td>
            <b>Nederlands (Dutch)</b>
          </td>
          <td>
            <b>Comment</b>
          </td>
          <td>
            <b>Version</b>
          </td>
        </tr>
        <tr>
          <td>ab
            <a name="ab"> </a>
          </td>
          <td>Abbott Laboratories</td>
          <td>Abbott Laboratories</td>
          <td>(includes Ross Products Division)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ad
            <a name="ad"> </a>
          </td>
          <td>Adams Laboratories, Inc.</td>
          <td>Adams Laboratories, Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>alp
            <a name="alp"> </a>
          </td>
          <td>Alpha Therapeutic Corporation</td>
          <td>Alpha Therapeutic Corporation</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ar
            <a name="ar"> </a>
          </td>
          <td>Armour</td>
          <td>Armour</td>
          <td>[Inactive--use AVB]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>avb
            <a name="avb"> </a>
          </td>
          <td>Aventis Behring L.L.C.</td>
          <td>Aventis Behring L.L.C.</td>
          <td>(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB]
               CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>avi
            <a name="avi"> </a>
          </td>
          <td>Aviron</td>
          <td>Aviron</td>
          <td/>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>ba
            <a name="ba"> </a>
          </td>
          <td>Baxter Healthcare Corporation</td>
          <td>Baxter Healthcare Corporation</td>
          <td>[Inactive--use BAH]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>bah
            <a name="bah"> </a>
          </td>
          <td>Baxter Healthcare Corporation</td>
          <td>Baxter Healthcare Corporation</td>
          <td>(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>bay
            <a name="bay"> </a>
          </td>
          <td>Bayer Corporation</td>
          <td>Bayer Corporation</td>
          <td>(includes Miles, Inc. and Cutter Laboratories)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>bp
            <a name="bp"> </a>
          </td>
          <td>Berna Products</td>
          <td>Berna Products</td>
          <td>[Inactive--use BPC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>bpc
            <a name="bpc"> </a>
          </td>
          <td>Berna Products Corporation</td>
          <td>Berna Products Corporation</td>
          <td>(includes Swiss Serum and Vaccine Institute Berne)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>cen
            <a name="cen"> </a>
          </td>
          <td>Centeon L.L.C.</td>
          <td>Centeon L.L.C.</td>
          <td>[Inactive--use AVB]</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>chi
            <a name="chi"> </a>
          </td>
          <td>Chiron Corporation</td>
          <td>Chiron Corporation</td>
          <td>[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and
               Evans Medical Limited CDC Changes made on: July 14, 2006</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>cmp
            <a name="cmp"> </a>
          </td>
          <td>Celltech Medeva Pharmaceuticals</td>
          <td>Celltech Medeva Pharmaceuticals</td>
          <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>cnj
            <a name="cnj"> </a>
          </td>
          <td>Cangene Corporation</td>
          <td>Cangene Corporation</td>
          <td>CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>con
            <a name="con"> </a>
          </td>
          <td>Connaught</td>
          <td>Connaught</td>
          <td>[Inactive--use PMC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>dvc
            <a name="dvc"> </a>
          </td>
          <td>DynPort Vaccine Company, LLC</td>
          <td>DynPort Vaccine Company, LLC</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>evn
            <a name="evn"> </a>
          </td>
          <td>Evans Medical Limited</td>
          <td>Evans Medical Limited</td>
          <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>geo
            <a name="geo"> </a>
          </td>
          <td>GeoVax Labs, Inc.</td>
          <td>GeoVax Labs, Inc.</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>gre
            <a name="gre"> </a>
          </td>
          <td>Greer Laboratories, Inc.</td>
          <td>Greer Laboratories, Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>iag
            <a name="iag"> </a>
          </td>
          <td>Immuno International AG</td>
          <td>Immuno International AG</td>
          <td>[Inactive--use BAH]</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>im
            <a name="im"> </a>
          </td>
          <td>Merieux</td>
          <td>Merieux</td>
          <td>[Inactive--use PMC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ius
            <a name="ius"> </a>
          </td>
          <td>Immuno-U.S., Inc.</td>
          <td>Immuno-U.S., Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>jpn
            <a name="jpn"> </a>
          </td>
          <td>The Research Foundation for Microbial Diseases of Osaka University</td>
          <td>The Research Foundation for Microbial Diseases of Osaka University</td>
          <td>(BIKEN)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>kgc
            <a name="kgc"> </a>
          </td>
          <td>Korea Green Cross Corporation</td>
          <td>Korea Green Cross Corporation</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>led
            <a name="led"> </a>
          </td>
          <td>Lederle</td>
          <td>Lederle</td>
          <td>[Inactive--use WAL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ma
            <a name="ma"> </a>
          </td>
          <td>Massachusetts Public Health Biologic Laboratories</td>
          <td>Massachusetts Public Health Biologic Laboratories</td>
          <td>[Inactive--use MBL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>mbl
            <a name="mbl"> </a>
          </td>
          <td>Massachusetts Biologic Laboratories</td>
          <td>Massachusetts Biologic Laboratories</td>
          <td>(formerly Massachusetts Public Health Biologic Laboratories)</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>med
            <a name="med"> </a>
          </td>
          <td>MedImmune, Inc.</td>
          <td>MedImmune, Inc.</td>
          <td/>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>mil
            <a name="mil"> </a>
          </td>
          <td>Miles</td>
          <td>Miles</td>
          <td>[Inactive--use BAY]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>mip
            <a name="mip"> </a>
          </td>
          <td>Bioport Corporation</td>
          <td>Bioport Corporation</td>
          <td>(formerly Michigan Biologic Products Institute)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>msd
            <a name="msd"> </a>
          </td>
          <td>Merck &amp; Co., Inc.</td>
          <td>Merck &amp; Co., Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>nab
            <a name="nab"> </a>
          </td>
          <td>NABI</td>
          <td>NABI</td>
          <td>(formerly North American Biologicals, Inc.)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>nav
            <a name="nav"> </a>
          </td>
          <td>North American Vaccine, Inc.</td>
          <td>North American Vaccine, Inc.</td>
          <td>[Inactive--use BAH]</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>nov
            <a name="nov"> </a>
          </td>
          <td>Novartis Pharmaceutical Corporation</td>
          <td>Novartis Pharmaceutical Corporation</td>
          <td>(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited,
               Ciba-Geigy Limited and Sandoz Limited)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>nvx
            <a name="nvx"> </a>
          </td>
          <td>Novavax, Inc.</td>
          <td>Novavax, Inc.</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>nyb
            <a name="nyb"> </a>
          </td>
          <td>New York Blood Center</td>
          <td>New York Blood Center</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>ort
            <a name="ort"> </a>
          </td>
          <td>Ortho-Clinical Diagnostics</td>
          <td>Ortho-Clinical Diagnostics</td>
          <td>(formerly Ortho Diagnostic Systems, Inc.)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>otc
            <a name="otc"> </a>
          </td>
          <td>Organon Teknika Corporation</td>
          <td>Organon Teknika Corporation</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>oth
            <a name="oth"> </a>
          </td>
          <td>Other manufacturer</td>
          <td>Andere fabrikant</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>pd
            <a name="pd"> </a>
          </td>
          <td>Parkedale Pharmaceuticals</td>
          <td>Parkedale Pharmaceuticals</td>
          <td>(formerly Parke-Davis)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>pmc
            <a name="pmc"> </a>
          </td>
          <td>sanofi pasteur</td>
          <td>sanofi pasteur</td>
          <td>(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories
               and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>prx
            <a name="prx"> </a>
          </td>
          <td>Praxis Biologics</td>
          <td>Praxis Biologics</td>
          <td>[Inactive--use WAL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>pwj
            <a name="pwj"> </a>
          </td>
          <td>PowderJect Pharmaceuticals</td>
          <td>PowderJect Pharmaceuticals</td>
          <td>(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC
               Changes made on: July 14, 2006</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>scl
            <a name="scl"> </a>
          </td>
          <td>Sclavo, Inc.</td>
          <td>Sclavo, Inc.</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>si
            <a name="si"> </a>
          </td>
          <td>Swiss Serum and Vaccine Inst.</td>
          <td>Swiss Serum and Vaccine Inst.</td>
          <td>[Inactive--use BPC]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>skb
            <a name="skb"> </a>
          </td>
          <td>GlaxoSmithKline</td>
          <td>GlaxoSmithKline</td>
          <td>(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>sol
            <a name="sol"> </a>
          </td>
          <td>Solvay Pharmaceuticals</td>
          <td>Solvay, Pharmaceuticals</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>tal
            <a name="tal"> </a>
          </td>
          <td>Talecris Biotherapeutics</td>
          <td>Talecris Biotherapeutics</td>
          <td>(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>unk
            <a name="unk"> </a>
          </td>
          <td>Unknown manufacturer</td>
          <td>Unknown manufacturer</td>
          <td/>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>usa
            <a name="usa"> </a>
          </td>
          <td>United States Army Medical Research and Material Command</td>
          <td>United States Army Medical Research and Material Command</td>
          <td/>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>vxg
            <a name="vxg"> </a>
          </td>
          <td>VaxGen</td>
          <td>VaxGen</td>
          <td>CDC Changes made on: July 14, 2006</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>wa
            <a name="wa"> </a>
          </td>
          <td>Wyeth-Ayerst</td>
          <td>Wyeth-Ayerst</td>
          <td>[Inactive--use WAL]</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>wal
            <a name="wal"> </a>
          </td>
          <td>Wyeth-Ayerst</td>
          <td>Wyeth-Ayerst</td>
          <td>(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories,
               and Praxis Biologics)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>zlb
            <a name="zlb"> </a>
          </td>
          <td>ZLB Behring</td>
          <td>ZLB Behring</td>
          <td>(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb.
               28, 2006</td>
          <td>added v2.6</td>
        </tr>
      </table>

    </div>
  </text>
  <url value="http://hl7.org/fhir/ValueSet/v2-0227"/>
  <version value="2.8.2"/>
  <name value="v2 Manufacturers of Vaccines (code=MVX)"/>
  <status value="active"/>
  <experimental value="true"/>
  <publisher value="HL7, Inc"/>
  <contact>
    <telecom>
      <system value="other"/>
      <value value="http://hl7.org"/>
    </telecom>
  </contact>
  <description value="FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines
     (code=MVX))"/>
  <compose>
    <include>
      <system value="http://hl7.org/fhir/v2/0227"/>
    </include>
  </compose>
</ValueSet>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.